Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,207 public trials 1,003 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Recruiting

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

NCT05873686

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +28 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

NCT05538130

Conditions
Advanced or Metastatic Solid Tumors, Brain Diseases, Brain Neoplasms, +41 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham - Phase I Clinical Trials Unit Birmingham, Alabama, United States
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
View all 83 locations
View Trial Details
Recruiting

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

NCT07174583

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +19 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
  • Fort Wayne Medical Oncology and Hematology, Inc. - Fort Wayne North Office Fort Wayne, Indiana, United States
  • START Midwest Grand Rapids, Michigan, United States
View all 13 locations
View Trial Details
Recruiting

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

NCT04302025

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 38 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

NCT07155187

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group - Springdale /ID# 277132 Springdale, Arkansas, United States
  • City of Hope National Medical Center /ID# 277005 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277928 Irvine, California, United States
  • Cancer Specialists of North Florida /ID# 277332 Jacksonville, Florida, United States
View all 110 locations
View Trial Details
Recruiting

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

NCT06562192

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +26 more
Locations
  • Uni of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California LA Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 29 locations
View Trial Details
Recruiting

Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients

NCT07242547

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Hospital General Universitario de Albacete Albacete, Spain
  • Hospital General Universitario Dr. Balmis de Alicante Alicante, Spain
  • Hospital General Universitario de Elche Elche, Alicante, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
View all 20 locations
View Trial Details

Related conditions